 | Up a level |
Perroud, Camille; Thurian, Dario; Andres, Martin; Künzi, Arnaud; Wiedemann, Gertrud; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas; Banz, Yara; Porret, Naomi; Rebmann, Ekaterina (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology, 41(5), pp. 912-921. Wiley 10.1002/hon.3208
Visentin, Andrea; Chatzikonstantinou, Thomas; Scarfò, Lydia; Kapetanakis, Anargyros; Demosthenous, Christos; Karakatsoulis, Georgios; Minga, Eva; Chamou, Dimitra; Allsup, David; Cabrero, Alejandro Alonso; Andres, Martin; Antic, Darko; Baile, Mónica; Baliakas, Panagiotis; Besikli-Dimou, Sotiria; Bron, Dominique; Chatzileontiadou, Sofia; Cordoba, Raul; Correa, Juan-Gonzalo; Cuéllar-García, Carolina; ... (2023). The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. American journal of hematology, 98(12), pp. 1856-1868. Wiley-Liss 10.1002/ajh.27093
Rebmann Chigrinova, Ekaterina; Porret, Naomi A; Andres, Martin; Wiedemann, Gertrud; Banz, Yara; Legros, Myriam; Pollak, Matthias; Oppliger Leibundgut, Elisabeth; Pabst, Thomas; Bacher, Ulrike (2022). Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias. BMC medical genomics, 15(1), p. 203. BioMed Central 10.1186/s12920-022-01346-1
Antic, Darko; Milic, Natasa; Chatzikonstantinou, Thomas; Scarfò, Lydia; Otasevic, Vladimir; Rajovic, Nina; Allsup, David; Alonso Cabrero, Alejandro; Andres, Martin; Baile Gonzales, Monica; Capasso, Antonella; Collado, Rosa; Cordoba, Raul; Cuéllar-García, Carolina; Correa, Juan Gonzalo; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Dimou, Maria; Doubek, Michael; ... (2022). Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. Journal of hematology & oncology, 15(1), p. 116. BioMed Central 10.1186/s13045-022-01333-0
Schenker, Carla; Hirzel, Cédric; Walti, Laura N.; Zeerleder, Sacha S.; Andres, Martin; Ramette, Alban; Barbani, Maria T.; Suter-Riniker, Franziska; Holbro, Andreas; Tritschler, Tobias (2022). Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response. British journal of haematology, 196(3), e27-e29. Wiley-Blackwell 10.1111/bjh.17806
Chatzikonstantinou, Thomas; Kapetanakis, Anargyros; Scarfò, Lydia; Karakatsoulis, Georgios; Allsup, David; Cabrero, Alejandro Alonso; Andres, Martin; Antic, Darko; Baile, Mónica; Baliakas, Panagiotis; Bron, Dominique; Capasso, Antonella; Chatzileontiadou, Sofia; Cordoba, Raul; Correa, Juan-Gonzalo; Cuéllar-García, Carolina; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Demosthenous, Christos; ... (2021). COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia, 35(12), pp. 3444-3454. Springer Nature 10.1038/s41375-021-01450-8
Andres, Martin; Feller, Anita; Arndt, Volker (2021). Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study. Swiss medical weekly, 151(w20463), w20463. EMH Schweizerischer Ärzteverlag 10.4414/smw.2021.20463
Pellegrini, Luca; Novak, Urban; Andres, Martin; Suter, Thomas; Nagler, Michael (2021). Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis. Critical reviews in oncology/hematology, 159, p. 103238. Elsevier 10.1016/j.critrevonc.2021.103238
Jalowiec, Katarzyna A.; Andres, Martin; Mansouri Taleghani, Behrouz; Musa, Albulena; Dickenmann, Martina; Angelillo-Scherrer, Anne; Rovó, Alicia; Kremer Hovinga, Johanna Anna (2020). Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature. Journal of medical case reports, 14(1), p. 206. BioMed Central 10.1186/s13256-020-02505-7
Scarfò, Lydia; Chatzikonstantinou, Thomas; Rigolin, Gian Matteo; Quaresmini, Giulia; Motta, Marina; Vitale, Candida; Garcia-Marco, Jose Antonio; Hernández-Rivas, José Ángel; Mirás, Fatima; Baile, Mónica; Marquet, Juan; Niemann, Carsten U; Reda, Gianluigi; Munir, Talha; Gimeno, Eva; Marchetti, Monia; Quaglia, Francesca Maria; Varettoni, Marzia; Delgado, Julio; Iyengar, Sunil; ... (2020). COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia, 34(9), pp. 2354-2363. Nature Publishing Group 10.1038/s41375-020-0959-x
Benz, Rudolf; Arn, Kornelius; Andres, Martin; Pabst, Thomas; Baumann, Michael; Novak, Urban; Hitz, Felicitas; Hess, Urs; Zenhaeusern, Reinhard; Chalandon, Yves; Mey, Ulrich; Blum, Sabine; Rauch, Daniel; O'Meara Stern, Alix; Cantoni, Nathan; Bargetzi, Mario; Bianchi-Papina, Elena; Rossi, Davide; Passweg, Jakob; Lohri, Andreas; ... (2020). Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood advances, 4(15), pp. 3699-3707. American Society of Hematology 10.1182/bloodadvances.2020002160
Rindlisbacher, Barbara; Schild, Christof; Egger, Florence; Bacher, Vera U.; Pabst, Thomas; Leichtle, Alexander; Andres, Martin; Sédille-Mostafaie, Nazanin (2020). Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio. The journal of applied laboratory medicine, 5(1), pp. 114-125. Oxford University Press 10.1093/jalm.2019.029330
Robertz, Judith; Andres, Martin; Mansouri Taleghani, Behrouz; Koneth, Irene; Binet, Isabelle; Kremer Hovinga, Johanna A. (2019). Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. American journal of hematology, 94(10), E259-E261. Wiley-Liss 10.1002/ajh.25583
Andres, Martin; Feller, Anita; Arndt, Volker (2018). Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013. Cancer epidemiology, biomarkers & prevention, 53, pp. 105-110. American Association for Cancer Research AACR 10.1016/j.canep.2018.01.015
Andres, Martin (2018). Die Ablösung der klassischen Zytostatika durch BCL-2- und BCR-Inhibitoren geht in die nächste Runde. Leading Opinions. Hämatologie & Onkologie, 14(1), pp. 28-30. Universimed
Berger, Martin Dave; Meisel, Alexander; Andres, Martin; Schanz, Urs; Schwarz, Urs; Stussi, Georg (2014). Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation. Journal of clinical oncology, 32(9), e33-e34. American Society of Clinical Oncology 10.1200/JCO.2012.47.5194
